Strides Pharma Science has agreed to sell its entire Australian business, including its local Arrow unit, to the Arrow-Apotex entity that resulted from the pair’s previously-announced merger, following a review of the Indian firm’s corporate strategy and the Australian market.
The decision comes as the Indian company is bolstering its presence in the US by converting its 50:50 joint venture with Vivimed Labs to 100% Strides ownership and acquiring Vensun Pharmaceuticals, as well as building out its Canadian operations with a majority stake in Pharmapar (Also see "